Literature DB >> 20618816

Chronic migraine with medication overuse pre-post withdrawal of symptomatic medication: clinical results and FMRI correlations.

Licia Grazzi1, Luisa Chiapparini, Stefania Ferraro, Susanna Usai, Frank Andrasik, Maria Luisa Mandelli, Maria Grazia Bruzzone, Gennaro Bussone.   

Abstract

BACKGROUND: Chronic migraine with symptomatic medication overuse (CMwMO) is a common and often debilitating clinical condition. Withdrawal of the offending drug(s) is considered the first step in management. Functional magnetic resonance imaging (fMRI) may be a useful technique for obtaining information on particular neuronal changes in the pain network involved in this condition.
OBJECTIVE: To identify specific fMRI patterns in patients suffering from CMwMO before and after withdrawal intervention.
METHODS: We collected fMRI data from a group of patients suffering from CMwMO, evaluating those patients prior to and 6 months following withdrawal. We applied stimuli at sites far removed from where the headaches were experienced. Moreover, pre-intervention fMRI data from the headache patients were compared with those obtained from headache-free and otherwise healthy controls.
RESULTS: Before withdrawal, the right supramarginal gyrus, the right inferior and superior parietal cortex were hypoactive. Activity recovered to almost normal 6 months after withdrawal of the offending medications.
CONCLUSIONS: The hypoactivation we detected in the lateral pain system indicate that there exists a modification of the pain network in CMwMO and that these changes are reversible with therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20618816     DOI: 10.1111/j.1526-4610.2010.01695.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  27 in total

Review 1.  Pathophysiology of medication-overuse headache: implications from animal studies.

Authors:  Saknan Bongsebandhu-phubhakdi; Anan Srikiatkhachorn
Journal:  Curr Pain Headache Rep       Date:  2012-02

Review 2.  Functional neuroimaging in migraine: usefulness for the clinical neurologist.

Authors:  Gioacchino Tedeschi; Antonio Russo; Alessandro Tessitore
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

3.  Subjectivity in primary headaches: insight the causes.

Authors:  Gennaro Bussone
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

Review 4.  Medication-overuse headache: a perspective review.

Authors:  Maria Lurenda Westergaard; Signe Bruun Munksgaard; Lars Bendtsen; Rigmor Højland Jensen
Journal:  Ther Adv Drug Saf       Date:  2016-06-30

5.  Combined effect of common gene variants on response to drug withdrawal therapy in medication overuse headache.

Authors:  Sarah Cargnin; Michele Viana; Grazia Sances; Marika Bianchi; Natascia Ghiotto; Cristina Tassorelli; Giuseppe Nappi; Pier Luigi Canonico; Armando A Genazzani; Salvatore Terrazzino
Journal:  Eur J Clin Pharmacol       Date:  2014-08-07       Impact factor: 2.953

Review 6.  Migrainomics - identifying brain and genetic markers of migraine.

Authors:  Dale R Nyholt; David Borsook; Lyn R Griffiths
Journal:  Nat Rev Neurol       Date:  2017-11-17       Impact factor: 42.937

7.  Clinical and psychosocial features of frequent relapsers (FR) among patients with chronic migraine and medication overuse.

Authors:  Alberto Raggi; Licia Grazzi; Roberta Ayadi; Matilde Leonardi; Alberto Proietti; Silvia Schiavolin; Chiara Scaratti; Susanna Usai; Domenico D'Amico
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

Review 8.  Functional imaging in chronic migraine.

Authors:  Farooq H Maniyar; Peter J Goadsby
Journal:  Curr Pain Headache Rep       Date:  2013-05

9.  Taking the headache out of migraine.

Authors:  David Borsook; David W Dodick
Journal:  Neurol Clin Pract       Date:  2015-08

Review 10.  Medication-overuse headache: risk factors, pathophysiology and management.

Authors:  Hans-Christoph Diener; Dagny Holle; Kasja Solbach; Charly Gaul
Journal:  Nat Rev Neurol       Date:  2016-09-12       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.